TOP NEWS

Valeant Pharmaceuticals Completes Coria Laboratories Buy

Aliso Viejo-based Valeant Pharmaceuticals International said Thursday that it has completed its acquisition of Coria Laboratories Ltd. The deal was worth $95M. Valeant had originally announced the acquisition of Coria Laboratories from its parent company, DFB Pharmaceuticals, on September 17th. Coria Laboratories is focused on dermatology products.


LATEST HEADLINES

More Headlines

BROWSE ISSUES